Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

(Radiolabeled androgens and progestins as imaging agents for tumors of the prostate and breast)

Technical Report ·
DOI:https://doi.org/10.2172/5622070· OSTI ID:5622070
The specific aims of the previous grant application can be summarized as follows: Synthesize fluorine-substituted progestins from the following high affinity classes: R5020 (promegestone), norgestrel, RU486, and retroprogestins; Synthesize fluorine-substituted androgens from the following high affinity classes: mibolerone, R1881 (metribolone) and 2-oxometribolone; Evaluate the receptor binding and non-specific binding of these fluorosteroids by in vitro binding assays; Develop and optimize fluoride ion substitution reactions suitable for the rapid, efficient and convenient preparation of these fluorosteroids in high specific activity, F-18 labeled form; and Evaluate the target tissue uptake of the F-18 labeled androgens and progestins in experimental animals.
Research Organization:
Illinois Univ., Urbana, IL (United States)
Sponsoring Organization:
DOE; USDOE, Washington, DC (United States)
DOE Contract Number:
FG02-86ER60401
OSTI ID:
5622070
Report Number(s):
DOE/ER/60401-T2; ON: DE92008729
Country of Publication:
United States
Language:
English

Similar Records

[Radiolabeled androgens and progestins as imaging agents for tumors of the prostate and breast]. Progress report
Technical Report · Mon Dec 30 23:00:00 EST 1991 · OSTI ID:10126688

(Fluorine-18 labeled androgens and progestins: Imaging agents for tumors of the prostate and breast)
Technical Report · Thu Sep 20 00:00:00 EDT 1990 · OSTI ID:6253152

Radiolabeled androgens and progestins as imaging agents for tumors of the prostate and breast
Technical Report · Sat Aug 08 00:00:00 EDT 1992 · OSTI ID:6853675